News

Perrigo CEO Patrick Lockwood-Taylor exits after three years due to conduct violation. Board names interim successor and reaffirms 2026...

GSK partners with Engitix on liver fibrosis regression targets in £44.5M deal focused on activating resolution pathways.

GNI Group to acquire Ayumi Pharmaceutical Holdings for ¥44.8 billion, gaining Calonal® acetaminophen dominance and Japanese distribution infrastructure.

Roche partners with Nurix on BTK degrader bexobrutideg for blood cancers, paying $700M upfront and splitting U.S. profits equally...

DaltonTx launches drug discovery platform with Sygnature Discovery to preserve medicinal chemistry decisions and reduce synthesis cycles.

BeyondSpring replaces founder as CEO ahead of the Plinabulin DUBLIN-4 Trial, its confirmatory Phase 3 study in NSCLC.

Drew Brees partners with ARS Pharmaceuticals to promote Neffy, a needle-free nasal spray for anaphylaxis approved by the FDA...

Scilex distributes 14 million Semnur Shares on June 15, 2026, retaining control of the sciatica-focused biotech behind Phase 3-validated...

ResMed acquires Noctrix Health for $340 million, gaining FDA-cleared Nidra wearable device for restless leg syndrome treatment.